Earnings results expected in 69 days
Summary
0R2B closed yesterday lower at $204.12, a decrease of 1.07% from Friday's close, completing a monthly decrease of -11.96% or $27.72. Over the past 12 months, 0R2B stock lost -11.96%.
0R2B pays dividends to its shareholders, with the most recent payment made on Jan 31, 2025. The next estimated payment will be in In 2 months on Apr 30, 2025 for a total of $0.27.
The last earnings report, released on Jan 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.78%, based on the last three reports. The next scheduled earnings report is due on Apr 21, 2025.
The stock of the company had never split.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on LSE (USD).
Want to track 0R2B and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0R2B Chart
FAQ
What Is the Danaher Corporation(0R2B) Stock Price Today?
The 0R2B stock price today is $204.12.
What Stock Exchange Does Danaher Corporation Trade On?
Danaher Corporation is listed and trades on the NYSE.
What Is the Stock Symbol for Danaher Corporation?
The stock symbol for Danaher Corporation is "0R2B".
Does Danaher Corporation Pay Dividends? What's The Current Dividend Yield?
0R2B is not paying dividends to its shareholders.
What Is the Danaher Corporation Market Cap?
As of today, Danaher Corporation does not have a market cap available.
What is Danaher Corporation Earnings Per Share?
The Danaher Corporation EPS is 0.
What Is the Next Danaher Corporation Earnings Date?
Danaher Corporation will release its next earnings report on Apr 21, 2025.
Did Danaher Corporation had any splits?
No, Danaher Corporation has never had a stock split.
Danaher Corporation Profile
| Diagnostics & Research Industry | Healthcare Sector | Mr. Steven M. Rales CEO | LSE Exchange | US2358511028 ISIN |
| US Country | 61,000 Employees | 27 Dec 2024 Last Dividend | 2 Oct 2023 Last Split | 5 Jan 1979 IPO Date |
Overview
Danaher Corporation is a global powerhouse in the design, manufacturing, and marketing of a vast array of professional, medical, industrial, and commercial products and services. With its inception in 1969 and a significant rebranding in 1984, where it transitioned from Diversified Mortgage Investors, Inc. to Danaher Corporation, the company has established a formidable presence in various sectors. Headquartered in Washington, D.C., Danaher stands out through its commitment to innovation, excellence, and enhancing the quality of life worldwide.
Products and Services
- Biotechnology: Danaher's biotechnology segment is a provider of bioprocess technologies, consumables, and services enhancing the development and manufacture of therapeutics. This includes cell line and cell culture media development, chromatography resins, filtration technologies, aseptic fill-finish solutions, single-use hardware, and comprehensive services aimed at setting up full manufacturing suites.
- Life Sciences: This segment delivers a wide range of products including mass spectrometers, flow cytometry, genomics solutions, lab automation instruments, centrifugation, liquid handling automation instruments, antibodies and reagents, particle counting and characterization tools, microscopes, and protein consumables. Among the notable brands under the Life Sciences segment are ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX, each providing specialized products for genomic medicines and industrial filtration.
- Diagnostics: Danaher’s diagnostics sector offers a comprehensive range of chemistry, immunoassay, microbiology, automation systems, molecular diagnostics, acute care, and pathology diagnostics products. Aimed at hospitals, physicians' offices, reference laboratories, and other critical care settings, this segment ensures the delivery of clinical instruments, reagents, consumables, software, and dedicated services to support critical diagnostics.
Contact Information
Address: 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701
Phone: 202 828 0850
Website: https://www.danaher.com
2025 © Marketlog. All Rights Reserved.
